EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 339 filers reported holding EXELIXIS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,456,000 | +282.2% | 92,914 | +346.4% | 0.00% | +200.0% |
| Q4 2021 | $381,000 | -11.8% | 20,814 | +2.0% | 0.00% | 0.0% |
| Q3 2021 | $432,000 | +17.1% | 20,402 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $369,000 | -17.4% | 20,246 | +2.3% | 0.00% | 0.0% |
| Q1 2021 | $447,000 | +13.5% | 19,791 | +0.8% | 0.00% | 0.0% |
| Q4 2020 | $394,000 | -21.2% | 19,643 | -4.1% | 0.00% | 0.0% |
| Q3 2020 | $500,000 | +2.5% | 20,478 | -0.2% | 0.00% | 0.0% |
| Q2 2020 | $488,000 | +31.5% | 20,518 | -4.6% | 0.00% | 0.0% |
| Q1 2020 | $371,000 | +12.4% | 21,498 | +14.9% | 0.00% | 0.0% |
| Q4 2019 | $330,000 | – | 18,712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |